These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1397777)

  • 21. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
    Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
    Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoglycemic thresholds for cognitive dysfunction in humans.
    Blackman JD; Towle VL; Lewis GF; Spire JP; Polonsky KS
    Diabetes; 1990 Jul; 39(7):828-35. PubMed ID: 2191886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study.
    Bingham EM; Dunn JT; Smith D; Sutcliffe-Goulden J; Reed LJ; Marsden PK; Amiel SA
    Diabetologia; 2005 Oct; 48(10):2080-9. PubMed ID: 16143864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term administration of theophylline and glucose recovery after hypoglycaemia in patients with type 1 diabetes mellitus.
    Hvidberg A; Rosenfalck A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Jul; 15(7):608-14. PubMed ID: 9686702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The duration of intrapartum maternal hyperglycaemia predicts neonatal hypoglycaemia in women with pre-existing diabetes.
    Joshi T; Oldmeadow C; Attia J; Wynne K
    Diabet Med; 2017 May; 34(5):725-731. PubMed ID: 28199038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin.
    McCrimmon RJ; Frier BM
    Diabet Med; 1997 Nov; 14(11):929-36. PubMed ID: 9400916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for Type 1 diabetes.
    Cheyne EH; Sherwin RS; Lunt MJ; Cavan DA; Thomas PW; Kerr D
    Diabet Med; 2004 Mar; 21(3):230-7. PubMed ID: 15008832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human insulin and awareness of acute hypoglycaemic symptoms in insulin-dependent diabetes.
    Patrick AW; Bodmer CW; Tieszen KL; White MC; Williams G
    Lancet; 1991 Aug; 338(8766):528-32. PubMed ID: 1678798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of insulin pump therapy: reduction of hypoglycaemia and impact on glycaemic control.
    Quirós C; Giménez M; Ríos P; Careaga M; Roca D; Vidal M; Conget I
    Diabet Med; 2016 Oct; 33(10):1422-6. PubMed ID: 26870914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes.
    Kerr D; Macdonald IA; Heller SR; Tattersall RB
    Diabetologia; 1990 Apr; 33(4):216-21. PubMed ID: 2347435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans.
    Fanelli C; Di Vincenzo A; Modarelli F; Lepore M; Ciofetta M; Epifano L; Pampanelli S; Brunetti P; Bolli GB
    Diabetologia; 1993 Nov; 36(11):1191-7. PubMed ID: 8270135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive function during hypoglycaemia in type I diabetes mellitus.
    Pramming S; Thorsteinsson B; Theilgaard A; Pinner EM; Binder C
    Br Med J (Clin Res Ed); 1986 Mar; 292(6521):647-50. PubMed ID: 3081208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity.
    Høi-Hansen T; Pedersen-Bjergaard U; Andersen RD; Kristensen PL; Thomsen C; Kjaer T; Høgenhaven H; Smed A; Holst JJ; Dela F; Boomsma F; Thorsteinsson B
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):216-29. PubMed ID: 19717500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of responses to acute hypoglycaemia induced by human and porcine insulins in patients with Type 1 diabetes.
    MacLeod KM; Gold AE; Frier BM
    Diabet Med; 1996 Apr; 13(4):346-57. PubMed ID: 9162611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acute hypoglycaemia on auditory information processing in adults with Type I diabetes.
    Strachan MW; Ewing FM; Frier BM; McCrimmon RJ; Deary IJ
    Diabetologia; 2003 Jan; 46(1):97-105. PubMed ID: 12637988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.